Orange Book - Pharma

Relevant Publications

Impact of Trauma Verification Level on Management and Outcomes of Combined Traumatic Brain and Solid Organ Injuries: An NTDB Retrospective Review.

Issue Release: 2024

The application of chemical similarity measures in an unconventional modeling framework c-RASAR along with dimensionality reduction techniques to a representative hepatotoxicity dataset.

Issue Release: 2024

PTB Regulates Keloid Fibroblast Migration and Proliferation Through Autophagy.

Issue Release: 2024

Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.

Issue Release: 2024

US Federal Trade Commission challenges Orange Book patent listings.

Issue Release: 2023

Global Harmonization of Immediate-Release Solid Oral Drug Product Bioequivalence Recommendations and the Impact on Generic Drug Development.

Issue Release: 2023

Role of global public sector research in discovering new drugs and vaccines.

Issue Release: 2023

The development of a novel simultaneous in vitro dissolution - in situ perfusion system as a potential tool for studying the absorption of solid oral formulation in rat.

Issue Release: 2023

Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019.

Issue Release: 2023

Chemical insights into the synthetic chemistry of five-membered saturated heterocycles-a transition metal-catalyzed approach.

Issue Release: 2023

The NBER Orange Book Dataset: A user\'s guide.

Issue Release: 2023

Nintedanib as the First Treatment for Group of Progressive Interstitial Lung Diseases: A Review of Patent Literature.

Issue Release: 2023

NIH funding for patents that contribute to market exclusivity of drugs approved 2010-2019 and the public interest protections of Bayh-Dole.

Issue Release: 2023

Fixing The FDA\'s Orange Book.

Issue Release: 2022

Evergreened drugs or evergreened profits?

Issue Release: 2022

Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.

Issue Release: 2022

Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimes.

Issue Release: 2022

Effect of Diameter and Fenestration Area of the Liposuction Cannula on the Viability of the Adipocytes.

Issue Release: 2022

Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data.

Issue Release: 2022

Patenting and patent challenges in South Korea after introducing a patent linkage system.

Issue Release: 2022

What is Transitional Care?

Why is Medication Adherence Important?

How Are Participants Protected?

What is the Future of the Pharmacy Profession?

What is an Abbreviated New Drug Application (ANDA)?

What are the Regulatory Requirements for Generic Drugs?

What is the Future of Patient Education in Pharma?

How Do Collaborative Care Models Work?

Who are Pharmacists?

What are the Challenges Faced by Generic Manufacturers?

Partnered Content Networks

Relevant Topics